SynthesisFrontiers in oncology2020

Comparative Efficacy and Safety of PARP Inhibitors as Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis.

Yangchun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.